series-b
Stage
1
Investors
About
Manas AI develops an AI-native biopharmaceutical platform that accelerates drug discovery by integrating physics-based and biologically informed AI models to improve the speed, cost efficiency, and precision of developing therapeutics across multiple modalities such as small molecules, antibodies, and siRNA.
Explore Manas AI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.